Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging. (Q49119848)
Jump to navigation
Jump to search
scientific article published on 21 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging. |
scientific article published on 21 August 2013 |
Statements
1 reference
Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging. (English)
1 reference
1 reference
Gengqian Cai
1 reference
Ahmed Tawakol
1 reference
Parmanand Singh
1 reference
James H F Rudd
1 reference
Joseph Soffer
1 reference
Esad Vucic
1 reference
Sarah P Brannan
1 reference
Elizabeth A Tarka
1 reference
Bonnie C Shaddinger
1 reference
Lea Sarov-Blat
1 reference
Sharath Subramanian
1 reference
Michael Farkouh
1 reference
Zahi A Fayad
1 reference
21 August 2013
1 reference
63
1 reference
1
1 reference
86-88
1 reference
Identifiers
1 reference